GHK-Cu (glycine-histidine-lysine copper) is a naturally occurring copper-binding tripeptide found in human blood plasma, saliva, and urine. Its levels decline significantly with age. It has been studied for wound healing, skin regeneration, anti-inflammatory effects, hair growth, and gene regulation. It is one of the most extensively researched peptide ingredients across both cosmetic and regenerative medicine research.
Wound Healing
GHK-Cu has been studied for wound healing since the 1970s. Research shows it accelerates wound closure, increases collagen and glycosaminoglycan synthesis, promotes new blood vessel formation, and reduces scar formation in animal and some human studies. It is used in some topical wound products.
Skin Aging Research
Multiple clinical studies have examined topical GHK-Cu for skin firmness, collagen density, and fine line reduction. A controlled clinical trial showed significant improvements in skin laxity and surface appearance with topical GHK-Cu application versus placebo.
Gene Regulation Research
More recent research has examined GHK-Cu's effects on gene expression using microarray technology. The compound appears to affect the expression of over 4,000 genes, generally moving them toward patterns associated with healthy younger tissue and away from patterns associated with inflammation and cancer biology.
Hair Growth
Studies have examined GHK-Cu as a topical treatment for hair thinning, with research suggesting it may extend the anagen (growth) phase of hair follicles and improve follicle density. Results are preliminary and larger trials are lacking.
Accelerates wound healing in animal and some human wound care studies.
Controlled topical trials show improvements in skin firmness, collagen density, and surface appearance.
Gene expression research shows broad effects on tissue remodeling and anti-inflammatory pathways.
Preliminary evidence for hair growth support.
Plasma levels drop significantly with age — from relatively high concentrations in youth to much lower levels by middle age.
Large randomized controlled trials for most applications are lacking. Skin research is often conducted with combination products making it hard to isolate GHK-Cu's specific contribution. Injectable use has a more limited research base than topical use and lacks established dosing in clinical trials. The gene regulation findings, while interesting, are based on cell culture and early translational research and require clinical validation.
GHK-Cu is a tripeptide that acts as a natural biological signal for tissue repair. After injury, the body produces and releases GHK-Cu at the wound site, where it tells surrounding cells to shift into rebuilding mode. It does this partly by carrying copper ions in a bioavailable form — copper is needed by enzymes that cross-link collagen and support antioxidant defenses — and partly through direct signaling effects on cells. As we age, the amount of GHK-Cu circulating in the blood drops significantly, which researchers believe may contribute to slower healing and reduced tissue maintenance. Topical or injectable GHK-Cu is studied as a way to restore those signals locally.
Topical GHK-Cu is widely used in cosmetic formulations and is generally considered well-tolerated. Systemic injectable use does not have a well-characterized safety profile from clinical trials. Copper toxicity is theoretically possible at high doses but the amounts used in typical topical or research protocols are far below levels associated with toxicity. It is not FDA-approved as a drug.
Moderate Evidence
This compound has been studied in Phase 1 or Phase 2 human trials. Evidence is encouraging but more large-scale trials are needed.
Published Research Ranges
0.05–5mg/kg in animal studies; topical and subcutaneous in human research
Research Context Only: These are ranges reported in published scientific studies for educational reference. They are not dosing recommendations. This is not medical advice. Always consult a qualified healthcare professional.
Sources listed here are from the platform research library. All links open the original publication. No citations are generated by AI.
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
BioMed Research International • 2015
• DOI: 10.1155/2015/648108
Liposomal Delivery Enhances the Effects of a Collagen Tripeptide-Containing Formulation on Dermal Structure and Optical Skin Parameters: A Randomized, Double-Blind, Placebo-Controlled Trial
Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants
Research Education Only: This profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions.
We use cookies to enhance your research experience and analyze platform usage. By continuing, you agree to our Cookie Policy.